BMS

For the project “BMS Leiden” TGM is realizing the facades of the new cell therapy facility of the American biopharmaceutical company BMS (Bristol Myers Squibb).

This new facility is being built within the Leiden Bio Science Park and will be used to produce and develop cell therapy mainly for leukemia patients.

The facade of the building consists of 8300 m² of aluminum curtain walling, which will be performed in the Schüco system. 3700 m² of the curtain wall will be covered with natural stone granulate panels, these panels will run across the building like a ribbon.

TGM is realizing the project on behalf of DPS Engineering B.V.